Sort
17,828 grants matching “crispr”
Identification of the genetic and transcriptomic networks of cognitive and neuropathological resilience to Alzheimerâs disease associated viruses
$1,105,054Benjamin Readhead · Arizona State University-Tempe Campus · U01 · FY2019 · AG
Identification of the genetic and transcriptomic networks of cognitive and neuropathological resilience to AlzheimerâÃÂÃÂs disease associated viruses
$1,104,719Benjamin Readhead · Arizona State University-Tempe Campus · U01 · FY2022 · AG
Collaborative Research: IMAGiNE: Quantifying Diatom Resilience in an Acidified Ocean
$1,101,964Nitin Baliga · Institute For Systems Biology · · FY2021 · BIO
Unconventional protein secretion-mediated protein quality control in health and diseases
$1,101,807Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Molecular Studies of Cellular Cytotoxicity
$1,101,773Stephen K Anderson · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Collaborative Research: EDGE FGT: Genome-wide knock-out mutant libraries for the microcrustacean Daphnia
$1,100,000Sen Xu · University Of Missouri-Columbia · · FY2023 · BIO
Chromatic Acclimation: A Novel Transcriptional Control System for Use in Optogenetics
$1,100,000David M Kehoe · Indiana University · · FY2025 · BIO
Collaborative Research: EDGE FGT: Genome-wide knock-out mutant libraries for the microcrustacean Daphnia
$1,099,894Michael E Pfrender · University Of Notre Dame · · FY2022 · BIO
A Patient-Centric Approach to Advance Functional Precision Oncology
$1,098,796Christopher J Kemp · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease
$1,098,582Carol A. Barnes · University Of Arizona · R01 · FY2025 · AG
The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer
$1,098,000Anjana Rao · La Jolla Institute For Immunology · R35 · FY2024 · CA
The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer
$1,098,000Anjana Rao · La Jolla Institute For Immunology · R35 · FY2025 · CA
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$1,096,673Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of a Nanoparticle-Based Gene Editing Technology for Neurological Applications
$1,096,057Krystof S Bankiewicz · Ohio State University · UH3 · FY2022 · NS
iPS-technology and patient specific disease models
$1,095,795Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Programmable RNA-targeting tools
$1,095,702Feng Zhang · Broad Institute, Inc. · R01 · FY2017 · HG
Viral Vector Core
$1,095,298Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2018 · ES
Optimization of an in vivo base editing strategy to treat SOD1-linked ALS
$1,093,040Thomas Gaj · University Of Illinois At Urbana-Champaign · U01 · FY2024 · NS
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines
$1,091,431Christopher A. Gaiteri · Rush University Medical Center · R01 · FY2021 · AG
Stanford Project 2
$1,091,369Calvin J Kuo · University Of California, San Francisco · U54 · FY2017 · CA
Genome 3D organization as a determinant of cell-fate decisions
$1,091,001Pedro Pereira Da Rocha · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2024 · AI
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2022 · AI
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2023 · AI
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2021 · AI